Cell signalling and radiation survival: The impact of protein phosphatases

References

• Adams DG, Coffee RL Jr, Zhang H, Pelech S, Strack S, Wadzinski BE. 2005. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. Journal of Biological Chemistry 280:42644–42654.
   PubMed Web of Science ®Google Scholar
• Biade S, Stobbe CC, Boyd JT, Chapman JD. 2001. Chemical agents that promote chromatin compaction radiosensitize tumour cells. International Journal of Radiation Biology 77:1033–1042.
   PubMed Web of Science ®Google Scholar
• Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. 2006. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine 354:567–578.
   PubMed Web of Science ®Google Scholar
• Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Molecular Cell 25:917–931.
   PubMed Web of Science ®Google Scholar
• Brunner TB, Geiger M, Grabenbauer GG, Lang-Welzenbach M, Mantoni TS, Cavallaro A, Sauer R, Hohenberger W, McKenna WG. 2008. Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. Journal of Clinical Oncology 26:2699–706.
   PubMedGoogle Scholar
• Busino L, Chiesa M, Draetta GF, Donzelli M. 2004. Cdc25A phosphatase: Combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 23:2050–2056.
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings of the National Academy of Science of the United States of America 96:4240–4245.
   PubMed Web of Science ®Google Scholar
• Chen JS, Zhou LJ, Entin-Meer M, Yang X, Donker M, Knight ZA, Weiss W, Shokat KM, Haas-Kogan D, Stokoe D. 2008. Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma. Molecular Cancer Therapeutics 7:841–850.
   PubMed Web of Science ®Google Scholar
• Chowdhury D, Keogh M, Ishii H, Peterson C, Buratowski S, Lieberman J. 2005. Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Molecular Cell 20:801–809.
   PubMed Web of Science ®Google Scholar
• Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, Dykxhoorn DM, Weinstock DM, Pfeifer GP, Lieberman J. 2008. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Molecular Cell 31:33–46.
   PubMed Web of Science ®Google Scholar
• Clarke PR, Siddhanti SR, Cohen P, Blackshear PJ. 1993. Okadaic acid-sensitive protein phosphatases dephosphorylate MARCKS, a major protein kinase C substrate. FEBS Letters 336:37–42.
   PubMedGoogle Scholar
• Cohen P. 2002a. The origins of protein phosphoryation. Nature Cell Biology 5:E127–130.
   Google Scholar
• Cohen PT. 2002b. Protein phosphatase 1–targeted in many directions. Journal of Cell Science 115:241–256.
   PubMed Web of Science ®Google Scholar
• Draetta G, Eckstein J. 1997. Cdc25 protein phosphatase in cell proliferation. Biochimica et Biophysica Acta 1332:M53–63.
   PubMed Web of Science ®Google Scholar
• Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H. 2003. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3:117–130.
   PubMed Web of Science ®Google Scholar
• Gao T, Brognard J, Newton AC. 2008. The phosphatase PHLPP controls the cellular levels of protein kinase C. Journal of Biological Chemistry 283:6300–6311.
   PubMed Web of Science ®Google Scholar
• Gao T, Furnari F, Newton AC. 2005. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Molecular Cell 18:13–24.
   PubMed Web of Science ®Google Scholar
• Grana TM, Rusyn EV, Zhou H, Sartor CI, Cox AD. 2002. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways. Cancer Research 62:4142–4150.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Cerniglia GJ, Mick R, Mckenna WG, Muschel RJ. 2005. HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. Cancer Research 65:8256–8265.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Li B, Cerniglia GJ, Ahmed MS, Hahn SM, Maity A. 2007. The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteosomal activity and inducing the unfolded protein response. Neoplasia 9:271–278.
   PubMedGoogle Scholar
• Hahn SM, Bernhard EJ, Regine W, Mohiuddin M, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Delaney TF, Kiel KD, Morrison B, Deutsch P, Muschel RJ, Mckenna WG. 2002a. A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clinical Cancer Research 8:1065–1072.
   PubMed Web of Science ®Google Scholar
• Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, Decaprio JA, Weinberg RA. 2002b. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Molecular Cell Biology 22:2111–2123.
   PubMed Web of Science ®Google Scholar
• Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ. 2001. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. Journal of Biological Chemistry 276:38830–38836.
   PubMed Web of Science ®Google Scholar
• Janssens V, Goris J. 2001. Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 353:417–439.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A. 2007. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Research 67:4467–4473.
   PubMed Web of Science ®Google Scholar
• Kao GD, Jiang Z, Fernandes AM, Gupta AK, Maity A. 2007. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. Journal of Biological Chemistry 282:21206–21212.
   PubMed Web of Science ®Google Scholar
• Keniry M, Parsons R. 2008. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27:5477–5485.
   PubMed Web of Science ®Google Scholar
• Kim IA, Bae SS, Fernandes A, Wu J, Muschel RJ, Mckenna WG, Birnbaum MJ, Bernhard EJ. 2005. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Research 65:7902–7910.
   PubMedGoogle Scholar
• Lankoff A, Bialczyk J, Dziga D, Carmichael WW, Gradzka I, Lisowska H, Kuszewski T, Gozdz S, Piorun I, Wojcik A. (2006). The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor. Mutagenesis 21:83–90.
   PubMed Web of Science ®Google Scholar
• Lechward K, Awotunde OS, Swiatek W, Muszynska G. 2001. Protein phosphatase 2A: Variety of forms and diversity of functions. Acta Biochimica Polonica 48:921–33.
   PubMed Web of Science ®Google Scholar
• Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. 2007. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 12:342–354.
   PubMed Web of Science ®Google Scholar
• MacKintosh C, Cohen P. 1989. Identification of high levels of type 1 and type 2A protein phosphatases in higher plants. Biochemical Journal 262:335–339.
   PubMed Web of Science ®Google Scholar
• MacKintosh C, Diplexcito J. 2003. Naturally ocurring inhibitors of protein serine/threonine phosphatases. In: Handbook of cell signaling. San Diego, CA: Academic Press, Ch 102, 607–612.
   Google Scholar
• Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry 273:13375–13378.
   PubMed Web of Science ®Google Scholar
• McConnell JL, Gomez RJ, McCorvey LR, Law BK, Wadzinski BE. 2007. Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway. Oncogene 26:6021–6030.
   PubMed Web of Science ®Google Scholar
• McKenna WG, Muschel RJ. 2003. Targeting tumor cells by enhancing radiation sensitivity. Genes, Chromosomes & Cancer 38:330–338.
   PubMedGoogle Scholar
• Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS. 2005. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. New England Journal of Medicine 353:2012–2024.
   PubMed Web of Science ®Google Scholar
• Mi J, Bolesta E, Brautigan D L, Larner JM. 2009a. PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53. Molecular Cancer Therapeutics 8:135–140.
   PubMedGoogle Scholar
• Mi J, Dziegielewski J, Bolesta E, Brautigan DL, Larner JM. 2009b. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS ONE 4:e4395.
   PubMed Web of Science ®Google Scholar
• Mumby MC, Walter G. 1993. Protein serine/threonine phosphatases: Structure, regulation, and functions in cell growth. Physiological Reviews 73:673–699.
   PubMed Web of Science ®Google Scholar
• Myers MP, Pass I, Batty IH, Van Der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proceedings of the National Academy of Science of the United States of America 95:13513–13518.
   PubMed Web of Science ®Google Scholar
• Pajonk F, Himmelsbach J, Riess K, Sommer A, McBride WH. 2002. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Research 62:5230–5235.
   PubMed Web of Science ®Google Scholar
• Park JK, Jung HY, Park SH, Kang SY, Yi MR, Um HD, Hong SH. 2008. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. International Journal of Radiation Oncology Biology and Physics 70:1552–1560.
   PubMed Web of Science ®Google Scholar
• Planchon SM, Waite KA, Eng C. 2008. The nuclear affairs of PTEN. Journal of Cell Science 121:249–253.
   PubMed Web of Science ®Google Scholar
• Prevo R, Deutsch E, Sampson O, Diplexcito J, Cengel K, Harper J, O'Neill P, McKenna WG, Patel S, Bernhard EJ. 2008. Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer Research 68:5915–5923.
   PubMed Web of Science ®Google Scholar
• Price WA, Stobbe CC, Park SJ, Chapman JD. 2004. Radiosensitization of tumour cells by cantharidin and some analogues. International Journal of Radiation Biology 80:269–279.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. 2006. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Molecular Cell 22:217–230.
   PubMed Web of Science ®Google Scholar
• Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B. 2001. A phosphatase associated with metastasis of colorectal cancer. Science 294:1343–1346.
   PubMed Web of Science ®Google Scholar
• Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. 2007. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128:157–170.
   PubMed Web of Science ®Google Scholar
• Sun L, Gao J, Dong X, Liu M, Li D, Shi X, Dong JT, Lu X, Liu C, Zhou J. 2008. EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A. [erratum appears in Proc Natl Acad Sci USA. 2008 Jul 1;105(26):9129]. Proceedings of the National Academy of Sciences of the United States of America 105:7153–7158.
   PubMedGoogle Scholar
• Tang X, Hui ZG, Cui XL, Garg R, Kastan MB, Xu B. 2008. A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage. Molecular Cell Biology 28:2559–2566.
   PubMedGoogle Scholar
• Tao Y, Zhang P, Girdler F, Frascogna V, Castedo M, Bourhis J, Kroemer G, Deutsch E. 2008. Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene 27:3244–3255.
   PubMed Web of Science ®Google Scholar
• Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, Dent P. 2007. Radiation-induced cell signaling: inside-out and outside-in. Molecular Cancer Therapeutics 6:789–801.
   PubMed Web of Science ®Google Scholar
• Van Kanegan MJ, Adams DG, Wadzinski BE, Strack S. 2005. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. Journal of Biological Chemistry 280:36029–36036.
   PubMed Web of Science ®Google Scholar
• Vanzyl W, Hahn WC, Sneddon AA, Stark M, Camier S, Werner M, Marck C, Sentenac A, Broach JR. 1992. Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cervisiae. Molecular Cell Biology 12:4946–4959.
   PubMedGoogle Scholar
• Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Reviews Cancer 2:489–501.
   PubMed Web of Science ®Google Scholar
• Wang J Kirby CE, Herbst R. 2002. The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. Journal of Biological Chemistry 277:46659–46668.
   PubMedGoogle Scholar
• Wang Z, Cao N, Nantajit D, Fan M, Liu Y, Li JJ. 2008a. Mitogen-activated protein kinase phosphatase-1 represses c-Jun NH2-terminal kinase-mediated apoptosis via NF-kappaB regulation. Journal of Biological Chemistry 283:21011–21023.
   PubMedGoogle Scholar
• Wang Z, Kar S, Carr BI. 2008b. Cdc25A protein phosphatase: a therapeutic target for liver cancer therapies. Anticancer Agents in Medicinal Chemistry 8:863–871.
   PubMedGoogle Scholar
• Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. 2007. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer 7:85.
   PubMedGoogle Scholar
• Wu X, Tatchell K. 2001. Mutations in yeast protein phosphatase type 1 that affect targeting subunit binding. Biochemistry 40:7410–7420.
   PubMedGoogle Scholar
• Yu J, Boyapati A, Rundell K. 2001. Critical role for SV40 small-t antigen in human cell transformation. Virology 290:192–198.
   PubMedGoogle Scholar
• Zhang W, Shi L. 2004. Evolution of the PPM-family protein phosphatases in Streptomyces: duplication of catalytic domain and lateral recruitment of additional sensory domains. Microbiology 150:4189–4197.
   PubMedGoogle Scholar